| Creating a reference distribution of predicted lung cancer risk |
Scott Lee |
Vanderbilt University Medical Center |
NLST |
Mar 8, 2021 |
NLST-763 |
| Nonparametric instrumental regression with competing risks data |
Ingrid Van Keilegom |
Katholieke Universiteit Leuven |
HIPB |
Mar 1, 2021 |
HIPB-2 |
| Association of Adulthood Weight Change with Lung Cancer Risk and Mortality |
Hyung-Suk Yoon |
Vanderbilt University Medical Center |
PLCO |
Feb 22, 2021 |
PLCO-738 |
| Detecting Medical Errors in the Cancer Screening Process: An In-Depth Review of Lung Cancer Screening & at Risk Qualifications |
Brianna Johnson |
University of Massachusetts Dartmouth |
PLCO |
Feb 22, 2021 |
PLCO-737 |
| Levering Interactive Diet and Activity Tracking Study Data to Inform Precision Dietary Assessment |
Regan Bailey |
Texas A&M University |
IDATA |
Feb 11, 2021 |
IDATA-41 |
| Unsupervised Deep Learning Detection of Lung Cancer Nodules |
Ouwen Huang |
Gradient Health |
NLST |
Feb 8, 2021 |
NLST-758 |
| A Lung Cancer Risk Prediction Model Through bio-Medical Data Using Rule Extraction and CT image abnormality detection |
Jerry Liu |
Prairie View A&M University |
NLST |
Feb 5, 2021 |
NLST-756 |
| Adding metabolite names from PLCO, ATBC studies to COMETS metabolite dictionary |
Steven Moore |
National Cancer Institute |
PLCO |
Feb 3, 2021 |
PLCO-733 |
| Novel Dietary Index for Gut Microbiota and Associations with Colorectal Cancer and Breast Cancer Risk |
Susan Steck |
University of South Carolina |
PLCO |
Jan 28, 2021 |
PLCO-730 |
| Time to Event Prediction Based on Risk Calculation from Biomarkers |
Anna Lokshin |
University of Pittsburgh |
PLCO |
Jan 28, 2021 |
PLCO-717 |
| Use of biometric data in cancer prediction |
Bonny Banerjee |
University of Memphis |
PLCO |
Jan 28, 2021 |
PLCOI-722 |
| Develop a Markovian-based natural history model for ovarian cancer progression |
Andrew Schaefer |
Rice University |
PLCO |
Jan 28, 2021 |
PLCO-729 |
| Impact of Anti-Inflammatory Medication Use on Breast Cancer Incidence and Survival in Elderly ER+ Breast Cancer |
Adrian Lee |
University of Pittsburgh Medical Center |
PLCO |
Jan 28, 2021 |
PLCO-725 |
| Explainable Machine Learning for Personalized Decision-Making in Prostate Cancer |
Krithika Suresh |
University of Colorado |
PLCO |
Jan 28, 2021 |
PLCO-726 |
| Training a mathematical model to estimate lung weight and volume using anthropometric and sociodemographic features |
Lygia Costa |
Independent Researcher |
NLST |
Jan 27, 2021 |
NLST-753 |
| Predicting Late Stage Cancer |
Paul Pinsky |
NCI |
PLCO |
Jan 25, 2021 |
PLCO-727 |
| Development of cell-free DNA (cfDNA) 5-hydroxymethylcytosine (5hmC) biomarkers for early detection of pancreatic ductal adenocarcinoma (PDAC) |
Marc Bissonnette |
University of Chicago |
PLCO |
Jan 15, 2021 |
2020-1003 |
| Evaluation of Interstitial Lung Abnormalities using a deep learning developed algorithm |
Anand Devaraj |
Royal Brompton & Harefield NHS Foundation Trust |
NLST |
Jan 14, 2021 |
NLST-751 |
| Association between socioeconomic status and colorectal cancer survival in patients participating in the PLCO cancer screening trial |
Laura Davis |
Independent |
PLCO |
Jan 14, 2021 |
PLCO-714 |
| The impact of body mass index (BMI) on cancer screening |
Sonja Berndt |
National Cancer Institute |
PLCO |
Jan 14, 2021 |
PLCO-716 |
